INVO Bioscience to Present at Tribe Public Event on April 13, 2021 News provided by Share this article SARASOTA, Fla., April 12, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's only in vivo Intravaginal Culture System, announced today that Steve Shum, CEO of INVO Bioscience, will present at Tribe Public's Webinar Presentation and Q&A Event titled " Democratizing Infertility - A Severely Underserved Global Market." The Event is scheduled to begin at 8:30 am Pacific/11:30 am Eastern on Tuesday, April 13, 2021. To register to join the complimentary, ZOOM webinar-based event, please visit Tribe Public LLC at INVO.TribePublic.com. Once registered, participants may begin forwarding their questions for INVO's management to Tribe Public at [email protected] or share their questions via the ZOOM chat feature during the event. Tribe Public's Managing Member, John F. Heerdink, Jr., will host the event and relay all questions to management.